Scinovex
review Open AccessTop 1% cited

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

The Lancet Infectious Diseases · 2020 · Vol. 21(6) · pp. e149–e162
Philipp KoehlerMatteo BassettiArunaloke ChakrabartiSharon C.‐A. ChenArnaldo Lopes ColomboMartin HoeniglН Н КлимкоCornelia Lass‐FlörlRita OladeleDonald C. VinhLiping ZhuBoris BöllRoger J. M. BrüggemannJean‐Pierre GangneuxJohn R. PerfectThomas F. PattersonThorsten PersigehlJacques F. MeisLuis Ostrosky‐ZeichnerP. Lewis WhitePaul E. VerweijOliver A. Cornely
Antifungal resistance and susceptibilityAntimicrobial Resistance in StaphylococcusBacterial biofilms and quorum sensingVoriconazoleIntensive care medicinePulmonary aspergillosisAspergillosisMedicineAspergillus fumigatusImmunologyAntifungalDermatology

MeSH terms

COVID-19SARS-CoV-2Amphotericin BAntifungal AgentsAzolesHumansNitrilesPyridinesTriazolesPulmonary AspergillosisCoinfectionVoriconazole
Citations
928
FWCI
16.18
field-weighted impact
References
93
Percentile
99%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance · Scinovex